These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1923330)
61. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651 [TBL] [Abstract][Full Text] [Related]
62. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children. Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035 [TBL] [Abstract][Full Text] [Related]
63. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis. Zicari AM; Zicari A; Nebbioso M; Mari E; Celani C; Lollobrigida V; Cesoni Marcelli A; Occasi F; Duse M Pediatr Allergy Immunol; 2014 Feb; 25(1):57-63. PubMed ID: 24236762 [TBL] [Abstract][Full Text] [Related]
64. [A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis]. Takamura E; Uchio E; Ebihara N; Okamoto S; Kumagai N; Shoji J; Nakagawa Y; Namba K; Fukushima A; Fujishima H; Miyazaki D; Ohashi Y Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):508-15. PubMed ID: 21735754 [TBL] [Abstract][Full Text] [Related]
65. Ocular surface disease: a case of vernal keratoconjunctivitis. Chigbu DI; Sandrasekaramudaly-Brown S Cont Lens Anterior Eye; 2011 Feb; 34(1):39-44. PubMed ID: 20971677 [TBL] [Abstract][Full Text] [Related]
66. Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis. Al-Amri AM; Mirza AG; Al-Hakami AM Middle East Afr J Ophthalmol; 2016; 23(1):135-8. PubMed ID: 26957853 [TBL] [Abstract][Full Text] [Related]
67. Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis. Fujishima H; Fukagawa K; Takano Y; Tanaka M; Okamoto S; Miyazaki D; Yamada J; Fukushima A; Uchio E; Nakagawa Y J Ocul Pharmacol Ther; 2009 Jun; 25(3):265-70. PubMed ID: 19348602 [TBL] [Abstract][Full Text] [Related]
68. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Mantelli F; Santos MS; Petitti T; Sgrulletta R; Cortes M; Lambiase A; Bonini S Br J Ophthalmol; 2007 Dec; 91(12):1656-61. PubMed ID: 17588996 [TBL] [Abstract][Full Text] [Related]
69. Corneal topographic response to intraocular pressure reduction in patients with vernal keratoconjunctivitis and steroid-induced glaucoma. Dada T; Konkal V; Tandon R; Singh R; Sihota R Eye (Lond); 2007 Feb; 21(2):158-63. PubMed ID: 16273087 [TBL] [Abstract][Full Text] [Related]
70. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis. Wan Q; Tang J; Han Y; Wang D; Ye H Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239 [TBL] [Abstract][Full Text] [Related]
71. Pharmacotherapy of rhinitis and rhinosinusitis. Chaaban M; Corey JP Facial Plast Surg Clin North Am; 2012 Feb; 20(1):61-71. PubMed ID: 22099618 [TBL] [Abstract][Full Text] [Related]
72. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058 [TBL] [Abstract][Full Text] [Related]